Skip to content

Harrow HROW Financing Cash Flow

Financing Cash Flow at other companies

AbbVie logo
AbbVieABBV
$919M+173%
Bausch + Lomb logo
Bausch + LombBLCO
-$20M-165%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$294K-93.0%
Viatris logo
ViatrisVTRS
-$203.8M+56.4%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$100M+31.5%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$1.2M-99.1%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's financing cash flow?
Harrow (HROW) reported financing cash flow of $48.91M in Q1 2026.
How has Harrow's financing cash flow changed year-over-year?
Harrow's financing cash flow increased by 212560.9% year-over-year, from $23K to $48.91M.
What is the long-term trend for Harrow's financing cash flow?
Over 3 years (2021 to 2024), Harrow's financing cash flow has grown at a -17.9% compound annual growth rate (CAGR), from $51.47M to $28.53M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.